ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

8 links0 made here, not in the record15 judgments2 judges (the rules as one: Rule based)6 record changes seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06524544A Study Comparing theCombination ofPembrolizumab andSacituzumab Govitecan-hziyVersus Standard of Care inthe Treatment of AdvancedUrothelial CancerNational Cancer Institute (NCIPhase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 29 · ClinicalTrials.gov record · Version of 2026-09-29Sep 30 · ClinicalTrials.gov record · Version of 2026-09-30Oct 1 · ClinicalTrials.gov record · Version of 2026-10-01Oct 5 · ClinicalTrials.gov record · Version of 2026-10-05Nov 4 · ClinicalTrials.gov record · Version of 2026-11-04Nov 12 · ClinicalTrials.gov record · Version of 2026-11-12Version of 2026-11-12CONDITIONSCarcinoma, Transitional CellThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSCarboplatinIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorCisplatinIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorDocetaxelIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorGemcitabineIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorPaclitaxelIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorPembrolizumabIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedSacituzumab govitecanIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Carboplatin

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Carboplatin”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Comparator
Comparator · 2

All judgments on this study

WhenLinkJudgeDecisionState
Sep 29The record itselfClinicalTrials.gov recordVersion of 2026-09-29Record change
Sep 30The record itselfClinicalTrials.gov recordVersion of 2026-09-30Record change
Oct 1The record itselfClinicalTrials.gov recordVersion of 2026-10-01Record change
Oct 5The record itselfClinicalTrials.gov recordVersion of 2026-10-05Record change
Nov 3CarboplatinClaude Opus 5.5ComparatorCurrent
Nov 3CisplatinClaude Opus 5.5ComparatorCurrent
Nov 3DocetaxelClaude Opus 5.5ComparatorCurrent
Nov 3GemcitabineClaude Opus 5.5ComparatorCurrent
Nov 3PaclitaxelClaude Opus 5.5ComparatorCurrent
Nov 3PembrolizumabClaude Opus 5.5TestedCurrent
Nov 3Sacituzumab govitecanClaude Opus 5.5TestedCurrent
Nov 4The record itselfClinicalTrials.gov recordVersion of 2026-11-04Record change
Nov 12The record itselfClinicalTrials.gov recordVersion of 2026-11-12Record change
Nov 18CarboplatinRule based · role ruleComparatorAgrees
Nov 18CisplatinRule based · role ruleComparatorAgrees
Nov 18DocetaxelRule based · role ruleComparatorAgrees
Nov 18GemcitabineRule based · role ruleComparatorAgrees
Nov 18PaclitaxelRule based · role ruleComparatorAgrees
Nov 18PembrolizumabRule based · role ruleTestedAgrees
Nov 18Sacituzumab govitecanRule based · role ruleTestedAgrees
As of nowCarcinoma, Transitional CellRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.